CLINICAL_TRIALS
trial_result
· 2024-10-10
Clinical Trial Update: Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL) [Phase 3]
Summary
The Phase 3 IMPAHCT-FUL trial evaluating inhaled imatinib for pulmonary arterial hypertension was terminated. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aerovate Therapeutics | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: TERMINATED | Results posted: 2024-10-10